Serum KL-6 level is increased in patients with pneumocystis pneumonia

S. Hirata, A. Yokoyama, H. Ohnishi, Y. Haruta, N. Ishikawa, K. Fujitaka, Y. Taooka, N. Hattori, H. Hamada, K. Nishimura, N. Kohno (Hiroshima, Toon, Japan; Denver, United States Of America)

Source: Annual Congress 2006 - Clinical management of interstitial lung disease
Session: Clinical management of interstitial lung disease
Session type: E-Posters in free access
Number: 668
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Hirata, A. Yokoyama, H. Ohnishi, Y. Haruta, N. Ishikawa, K. Fujitaka, Y. Taooka, N. Hattori, H. Hamada, K. Nishimura, N. Kohno (Hiroshima, Toon, Japan; Denver, United States Of America). Serum KL-6 level is increased in patients with pneumocystis pneumonia. Eur Respir J 2006; 28: Suppl. 50, 668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Serum indicators for the diagnosis of pneumocystis pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 559s
Year: 2006

Serum levels of IL-6 in severe community-acquired pneumonia
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010

Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

Serum procalcitonin and community-acquired pneumonia in childhood
Source: Eur Respir J 2005; 26: Suppl. 49, 167s
Year: 2005

YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis.
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019

Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Elevated troponin and creatinine levels are associated with higher mortality in community-acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 488s
Year: 2006

Elevated levels of BALF galectin-9 in patients with interstitial pneumonia
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010

Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007


Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 825s
Year: 2006

Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 336s
Year: 2003

Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
Source: Eur Respir J 2005; 25: 688-692
Year: 2005



Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Source: Eur Respir J 2008; 31: 356-362
Year: 2008